Free Trial

Drägerwerk AG & Co. KGaA (ETR:DRW3) Stock Price Down 2.2% - Time to Sell?

Drägerwerk AG & Co. KGaA logo with Medical background

Drägerwerk AG & Co. KGaA (ETR:DRW3 - Get Free Report) shares were down 2.2% on Friday . The stock traded as low as €45.20 ($46.60) and last traded at €45.25 ($46.65). Approximately 6,213 shares were traded during trading, a decline of 82% from the average daily volume of 33,804 shares. The stock had previously closed at €46.25 ($47.68).

Drägerwerk AG & Co. KGaA Stock Performance

The company has a market capitalization of $389.15 million, a PE ratio of 7.33, a price-to-earnings-growth ratio of 1.24 and a beta of -0.31. The company has a current ratio of 1.88, a quick ratio of 0.81 and a debt-to-equity ratio of 32.13. The business's fifty day moving average is €45.22 and its two-hundred day moving average is €46.80.

About Drägerwerk AG & Co. KGaA

(Get Free Report)

Drägerwerk AG & Co KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Drägerwerk AG & Co. KGaA Right Now?

Before you consider Drägerwerk AG & Co. KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Drägerwerk AG & Co. KGaA wasn't on the list.

While Drägerwerk AG & Co. KGaA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines